You are here

Search results

(1 - 20 of 29)

Pages

Title: Biomanufacturing Strategies, Datamonitor report
Description: Biotechnology companies have limited resources and must decide whether to devote these to building manufacturing plants or to outsourcing projects.
Date: 2007-09-28

Title: Intellectual Property and Outsourcing in China, Datamonitor report
Description: The pharma outsourcing industry in China has experienced over 35% year on year growth in the past few years. Increasingly, the sophisticated service offer of multinational CROs/CMOs is being challenged by improving Chinese players.
Date: 2008-12-01

Title: Emerging Clinical Trial Locations � India, Datamonitor report
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment na�ve patients from large patient pool, cost benefits associated with lower labor and service fees.
Date: 2009-06-17

Title: Key Trends in Offshoring Pharmaceutical R&D, Datamonitor report
Description: This report discusses the offshore R&D strategies adopted by the industry to improve productivity and efficiency. It covers a variety of strategic partnerships, academic collaborations, and outsourcing opportunities.
Date: 2009-03-01

Title: The Top 10 Contract Research Organizations, Datamonitor report
Description: Cost containment and regulatory pressures within the pharma industry are driving R&D outsourcing across the globe. As a result, the CRO industry is expanding, and the global market is predicted to value $35bn by 2013.
Date: 2009-03-16

Title: Emerging Clinical Trial Locations � China, Datamonitor report
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment na�ve patients from large patient pool, cost benefits associated with lower labor and service fees.
Date: 2009-06-17

Title: Contract Manufacturing Strategies, Datamonitor report
Description: Pharmaceutical companies must have agility in their manufacturing processes to keep their supply chains aligned with significant shifts in global product demand. The total control of the drug development chain has been a key approach.
Date: 2008-06-01

Title: Emerging Clinical Trial Locations � Latin America, Datamonitor report
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment na�ve patients from large patient pool, cost benefits associated with lower labor and service fees.
Date: 2009-06-17

Title: Emerging Clinical Trial Locations � Eastern Europe, Datamonitor report
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment na�ve patients from large patient pool, cost benefits associated with lower labor and service fees.
Date: 2009-06-17

Title: Key Players in Pharmaceutical Contract Manufacturing, Datamonitor report
Description: The pharmaceutical contract manufacturing industry continues to grow, driven by mounting industry pressures. The highly competitive nature of the industry has been driving consolidation and companies are increasingly offshoring to emerging markets.
Date: 2009-03-23

Title: Patient Recruitment and Retention in Clinical Trials, Datamonitor report
Description: Clinical trials are increasingly becoming a bottleneck as recruiting patients in established markets becomes increasingly difficult. To address this CROs and other clinical specialists have developed a number of strategies with varying success.
Date: 2007-05-31

Title: Optimizing Partnerships with Contract Organizations, Datamonitor report
Description: Partnerships with contract organizations can help to develop closer relationships between sponsors and contractors, facilitating a mutual understanding of organizational structure, culture and priority that can lead to improved project outcomes.
Date: 2007-11-16

Title: Emerging Clinical Trial Locations, Datamonitor report
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment na�ve patients from large patient pool, cost benefits associated with lower labor and service fees.
Date: 2009-06-22

Title: The CMO Market Outlook to 2017, Datamonitor report
Description: A weak economy combined with increasingly uncertain regulatory and payer environments are driving pharma companies to cut internal manufacturing, creating a strong contract manufacturing market. Emerging regions will account for the greatest growth.
Date: 2012-02-17

Title: Risk Sharing and Innovative Contracting with CROs, Datamonitor report
Description: CROs are seeking greater upside from royalties and other opportunities to participate in profits. Meanwhile, drugmakers have an interest in reducing upfront drug development costs, and reducing the financial risks of product failure.
Date: 2011-02-17

Title: Optimizing Clinical Trials Through IT, Datamonitor report
Description: Amidst pressing needs to accelerate drug development while controlling costs, pharma companies and CROs are using new information technologies to improve clinical trials. This report examines these technologies and how they can be best applied.
Date: 2011-05-31

Title: The CRO Market Outlook to 2016, Datamonitor report
Description: The CRO market continues to undergo strong growth despite a soft economy and ongoing pressures on drug developers. The industry is evolving through mergers and acquisitions and changing contracting and relationship models.
Date: 2011-11-18

Title: New Emerging R&D and Clinical Trial Locations, Datamonitor report
Description: Wage inflation and competition for sites are driving up costs in key emerging R&D locations. Pharma companies are taking an increasingly strategic approach to outsourcing, and are competing on how efficiently they can use it to develop products.
Date: 2012-01-04

Title: The CMO Market Outlook, Datamonitor report
Description: Falling productivity and patent expiries are placing increasing pressure on pharmaceutical companies to reduce fix costs. Sponsors are turning to CMOs in search of time and cost savings and as a way to flexibly manage outsourced manufacturing.
Date: 2009-11-04

Title: The Future of R&D Outsourcing, Datamonitor report
Description: This report investigates current and ongoing issues affecting decisions on whether or not to outsource R&D. Outsourcing, particularly to low cost offshore venues like India and China, offers a way to maintain productivity within new cost parameters.
Date: 2010-01-04

Pages